Olmesartan potentiates the anti-angiogenic effect of sorafenib in mice bearing Ehrlich's ascites carcinoma: role of angiotensin (1-7).
Local renin-angiotensin systems exist in various malignant tumor tissues; this suggests that the main effector peptide, angiotensin II, could act as a key factor in tumor growth. The underlying mechanisms for the anti-angiogenic effect of angiotensin II type 1 receptor blockers need to be further ev...
Main Authors: | Mohammad M Abd-Alhaseeb, Sawsan A Zaitone, Soad H Abou-El-Ela, Yasser M Moustafa |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3899087?pdf=render |
Similar Items
-
Antitumor activity of methoxylated flavonoids separated from Achillea fragrantissima extract in Ehrlich’s ascites carcinoma model in mice
by: Basma M. Awad, et al.
Published: (2020-01-01) -
Formate metabolism in Ehrlich ascites carcinoma.
by: Herscovics, Annette. A.
Published: (1962) -
Plasma membrane antigens of the Ehrlich ascites carcinoma
by: Davis, J. M.
Published: (1980) -
Biochemical and pathological studies on the effects of levamisole and chlorambucil on Ehrlich ascites carcinoma-bearing mice
by: Fakhry S. Salem, et al.
Published: (2011-01-01) -
In vivo production of tumor necrosis factor for the treatment of Ehrlich ascites tumor bearing mice.
Published: (1990)